INHIBITION OF HUMAN PHOSPHOLIPASE-C BY AUROTHIOMALATE AND (TRIETHYLPHOSPHINE) GOLD COMPLEXES

被引:0
作者
MARKI, F
STANTON, JL
机构
[1] CIBA GEIGY AG,RES DEPT,DIV PHARMACEUT,CH-4002 BASEL,SWITZERLAND
[2] CIBA GEIGY CORP,RES DEPT,DIV PHARMACEUT,SUMMIT,NJ 07901
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1992年 / 42-1卷 / 03期
关键词
ANTIRHEUMATIC DRUGS; AURANOFIN; AUROTHIOMALATE COMPLEX; INVITRO STUDIES; 4-CHLOROMERCURIBENZOIC ACID; CHRYSOTHERAPY; GOLD CHLORIDE; GOLD COMPLEXES; MERCURIC CHLORIDE; PHOSPHOLIPASE-C; HUMAN PLATELET; INHIBITION; (TRIETHYLPHOSPHINE)GOLD COMPLEX; ANALOGS;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of several gold complexes on the activity of phospholipase C from human blood platelets was studied in vitro. Aurothiomalate and auranofin - 2 agents used for the chrysotherapy of rheumatoid arthritis-, gold chloride, (triethylphosphine)gold chloride, and 5 newly synthesized (triethylphosphine)gold complexes dose-dependently inhibited the enzyme with IC50 values between 0.8-mu-mol/l ((triethylphosphine)gold chloride) and over 100-mu-mol/l (auranofin). None of the compounds affected phospholipase A2 from human polymorphonuclear leukocytes at concentrations up to 100-mu-mol/l. Inhibition of phospholipase C by (triethylphosphine)gold chloride, aurothiomalate, and compound 3 was not significantly different at substrate concentrations of 20 and 100-mu-mol/l phosphatidylinositol, suggesting that these gold complexes do not inhibit phospholipase C by competing with the substrate. After confirming the Ca2+ dependence of the human platelet phospholipase C by demonstrating inhibition by the Ca2+ chelators EDTA and EGTA - but no inhibition by the Zn2+ chelator 1,10-phenanthroline - the inhibition of the enzyme by (triethylphosphine)gold chloride, aurothiomalate, and compound 3 was studied at 3 different concentrations of Ca2+ in the range of 0.2 to 2 mmol/l. Inhibition by (triethylphosphine)gold chloride was not affected by changes of Ca2+, whereas inhibition by aurothiomalate and compound 3 was markedly suppressed by increasing the Ca2+ concentration. This indicates that inhibition of phospholipase C by the latter 2 compounds could be due to competition with Ca2+ within the active site of the enzyme. Mercuric chloride and 4-chloromercuribenzoic acid were found to be potent inhibitors of phospholipase C (IC50 0.6 and 1.2-mu-mol/l, respectively), whereas the alkylating agents N-ethyl-maleimide and iodoacetamide, and the thiol compounds 2-mercaptoethanol and 1,4-dithio-D,L-threitol (DTT) had no significant effect. However, when the above 2 mercurials or the gold complexes (triethylphosphine)gold chloride and aurothiomalate were preincubated with the enzyme in the presence of an excess of 2-mercaptoethanol, inhibition was completely prevented. These results suggest that gold complexes and mercurials inhibit human platelet phospholipase C by blockade of an essential sulfhydryl group of the enzyme.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 35 条
[1]   AURANOFIN STIMULATES LTA HYDROLASE AND INHIBITS 5-LIPOXYGENASE LTA SYNTHASE ACTIVITY OF ISOLATED HUMAN NEUTROPHILS [J].
BETTS, WH ;
HURST, NP ;
MURPHY, GA ;
CLELAND, LG .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (07) :1233-1237
[2]   ENHANCED PHOSPHOLIPASE-A2 AND C ACTIVITIES OF PERIPHERAL-BLOOD POLYMORPHONUCLEAR LEUKOCYTES FROM PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
BOMALASKI, JS ;
CLARK, MA ;
DOUGLAS, SD ;
ZURIER, RB .
JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (05) :649-654
[3]   ENHANCED PHOSPHOLIPASE-ACTIVITY IN PERIPHERAL-BLOOD MONOCYTES FROM PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
BOMALASKI, JS ;
CLARK, MA ;
ZURIER, RB .
ARTHRITIS AND RHEUMATISM, 1986, 29 (03) :312-318
[4]   LEUKOTRIENES IN INFLAMMATION [J].
BRAY, MA .
AGENTS AND ACTIONS, 1986, 19 (1-2) :87-99
[5]  
CROOKE ST, 1987, SCAND J RHEUMATOL S, V63, P1
[6]   DESIGN OF POTENT COMPETITIVE INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - CARBOXYALKANOYL AND MERCAPTOALKANOYL AMINO-ACIDS [J].
CUSHMAN, DW ;
CHEUNG, HS ;
SABO, EF ;
ONDETTI, MA .
BIOCHEMISTRY, 1977, 16 (25) :5484-5491
[7]   LACK OF CORRELATION BETWEEN BLOOD GOLD CONCENTRATIONS AND CLINICAL-RESPONSE IN PATIENTS WITH DEFINITE OR CLASSIC RHEUMATOID-ARTHRITIS RECEIVING AURANOFIN OR GOLD SODIUM THIOMALATE [J].
DAHL, SL ;
COLEMAN, ML ;
WILLIAMS, HJ ;
ALTZSMITH, M ;
KAY, DR ;
PAULUS, HE ;
WEINSTEIN, A ;
KAPLAN, S .
ARTHRITIS AND RHEUMATISM, 1985, 28 (11) :1211-1218
[8]  
DANIS VA, 1990, CLIN EXP IMMUNOL, V79, P335
[9]  
FORDHUTCHINSON AW, 1986, LEUKOTRIENES THEIR B, P141
[10]  
Forestier J, 1932, LANCET, V1, P441